Financials Centrum Medyczne ENEL-MED S.A.
Equities
ENE
PLENLMD00017
Healthcare Facilities & Services
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
17.8 PLN | 0.00% | -3.78% | -6.32% |
Valuation
Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|---|
Capitalization 1 | 282.6 | 245.1 | 306.4 | 377.1 | 500.6 | 444 |
Enterprise Value (EV) 1 | 321.4 | 291.6 | 554.4 | 601.3 | 630.7 | 635.6 |
P/E ratio | -85.5 x | -333 x | -124 x | -111 x | -443 x | -18.8 x |
Yield | - | - | - | - | - | - |
Capitalization / Revenue | 0.87 x | 0.66 x | 0.73 x | 0.94 x | 1.13 x | 0.9 x |
EV / Revenue | 0.99 x | 0.78 x | 1.33 x | 1.5 x | 1.43 x | 1.28 x |
EV / EBITDA | 17.7 x | 12.5 x | 21.3 x | 16.8 x | 25.8 x | 115 x |
EV / FCF | -27.7 x | -198 x | 19.1 x | 11.3 x | - | 647 x |
FCF Yield | -3.61% | -0.51% | 5.24% | 8.86% | - | 0.15% |
Price to Book | 2.67 x | 2.34 x | 2.99 x | 3.81 x | 2.83 x | 2.92 x |
Nbr of stocks (in thousands) | 23,567 | 23,567 | 23,567 | 23,567 | 28,280 | 28,280 |
Reference price 2 | 11.99 | 10.40 | 13.00 | 16.00 | 17.70 | 15.70 |
Announcement Date | 4/25/18 | 4/18/19 | 4/22/20 | 4/28/21 | 4/27/22 | 4/27/23 |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|---|
Net sales 1 | 323.7 | 371.7 | 417.7 | 399.8 | 441.1 | 494.9 |
EBITDA 1 | 18.2 | 23.38 | 26.06 | 35.69 | 24.46 | 5.528 |
EBIT 1 | -1.373 | 1.546 | 3.701 | 13.36 | 2.108 | -19.7 |
Operating Margin | -0.42% | 0.42% | 0.89% | 3.34% | 0.48% | -3.98% |
Earnings before Tax (EBT) 1 | -3.509 | 0.032 | -1.017 | -4.478 | 0.616 | -27.94 |
Net income 1 | -3.306 | -0.735 | -2.468 | -3.395 | -0.89 | -23.56 |
Net margin | -1.02% | -0.2% | -0.59% | -0.85% | -0.2% | -4.76% |
EPS 2 | -0.1403 | -0.0312 | -0.1047 | -0.1441 | -0.0400 | -0.8330 |
Free Cash Flow 1 | -11.59 | -1.473 | 29.05 | 53.27 | - | 0.9826 |
FCF margin | -3.58% | -0.4% | 6.95% | 13.32% | - | 0.2% |
FCF Conversion (EBITDA) | - | - | 111.47% | 149.25% | - | 17.78% |
FCF Conversion (Net income) | - | - | - | - | - | - |
Dividend per Share | - | - | - | - | - | - |
Announcement Date | 4/25/18 | 4/18/19 | 4/22/20 | 4/28/21 | 4/27/22 | 4/27/23 |
Income Statement Evolution (Quarterly data)
Fiscal Period: December | 2021 Q2 | 2022 Q1 | 2022 S1 | 2022 Q3 |
---|---|---|---|---|
Net sales 1 | 109.3 | 115.1 | - | 124.3 |
EBITDA | 13.05 | 9.425 | - | - |
EBIT 1 | -1.169 | -5.692 | - | -3.439 |
Operating Margin | -1.07% | -4.94% | - | -2.77% |
Earnings before Tax (EBT) | - | - | - | - |
Net income | 1.391 | - | -19.2 | - |
Net margin | 1.27% | - | - | - |
EPS | - | - | -0.6800 | - |
Dividend per Share | - | - | - | - |
Announcement Date | 9/28/21 | 5/30/22 | 9/28/22 | 11/29/22 |
Balance Sheet Analysis
Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|---|
Net Debt 1 | 38.8 | 46.5 | 248 | 224 | 130 | 192 |
Net Cash position 1 | - | - | - | - | - | - |
Leverage (Debt/EBITDA) | 2.132 x | 1.99 x | 9.518 x | 6.282 x | 5.321 x | 34.67 x |
Free Cash Flow 1 | -11.6 | -1.47 | 29 | 53.3 | - | 0.98 |
ROE (net income / shareholders' equity) | -3.08% | -0.7% | -2.38% | -3.37% | -0.65% | -14.4% |
ROA (Net income/ Total Assets) | -0.42% | 0.45% | 0.73% | 2.07% | 0.32% | -2.83% |
Assets 1 | 779.5 | -161.9 | -337.1 | -164.2 | -282.2 | 832.4 |
Book Value Per Share 2 | 4.500 | 4.440 | 4.340 | 4.200 | 6.260 | 5.380 |
Cash Flow per Share 2 | 0.3200 | 0.2400 | 0.3500 | 0.7600 | 2.640 | 0.8300 |
Capex 1 | 28.7 | 20 | 29.4 | 10.9 | - | 45.9 |
Capex / Sales | 8.88% | 5.37% | 7.03% | 2.73% | - | 9.28% |
Announcement Date | 4/25/18 | 4/18/19 | 4/22/20 | 4/28/21 | 4/27/22 | 4/27/23 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Chiffre d''affaires - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-6.32% | 124M | |
-28.69% | 70.69B | |
+14.32% | 81.84B | |
+9.37% | 29.03B | |
-11.43% | 16.97B | |
+0.64% | 16.83B | |
-0.24% | 15.28B | |
+6.22% | 12.41B | |
+33.40% | 12.26B | |
-31.40% | 11.83B |
- Stock Market
- Equities
- ENE Stock
- Financials Centrum Medyczne ENEL-MED S.A.